Chronic Kidney Disease
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1) Patients who have moderate chronic kidney disease *eGFR: 30-59 ml/min/1.73m2 2) Patients who are aged 20 years or older at the time of obtaining informed consent 3) Patients who have personally and voluntarily provided written informed consent, after having received and thoroughly understood an adequate explanation about participation in the study.
Exclusion criteria
Exclusion criteria: 1) Patients receiving AST-120 2) Patients who have gastrointestinal obstruction 3) Women of confirmed or potential pregnancy 4) Patients who participated in other clinical trials within 3 months of administrating the experimental drugs 5) Patients who are judged unsuitable for this study by the doctor in charge of the patients
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| coronary artery calcification score at 36 months | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. eGFR, BUN and BNP at 36 months 2. coronary artery calcification score at 24 and 36 months | — |
Countries
Japan
Contacts
Tosei General Hospital Department of Cardiology